Wearable Contextual Engine for Automatic Pharmaceutical Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing pharmaceutical delivery mechanisms, such as time-released pills and RF-activated nanoparticles, require user interaction or healthcare provider intervention, leading to delayed therapeutic effects and potential discomfort due to side effects like liver damage and drowsiness.
Innovation Solution
A wearable device with a contextual engine that uses various sensors and inputs to automatically activate pharmaceuticals already in the body by emitting signals in response to detected contexts, such as physical activity, location, or biometric states, ensuring timely therapeutic effects without user interaction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If time-released pharmaceuticals are used, then the duration of therapeutic effect is extended, but the response time is delayed and side effects occur during the waiting period
Solution Approach 1:
The pharmaceutical is administered in advance and held in a dormant state within the body, ready for immediate activation. The wearable device keeps the drug in a reservoir or encapsulated form until the contextual trigger occurs, at which point activation is immediate rather than waiting for gradual release from time-released formulations.
Solution Approach 2:
The system changes the activation state of the pharmaceutical from dormant to active through external stimulation (such as magnetic field, light, or thermal trigger from the wearable device). This parameter change allows the drug to remain in the body without effect until needed, then activate rapidly when the contextual condition is met.
2Object-affected harmful factors
If conditional release pharmaceuticals are used, then side effects are reduced, but user interaction or provider intervention is required
Solution Approach 1:
The system uses sensors within the wearable device to automatically detect contextual conditions (such as pain indicators, activity level, location, or biometric data) and triggers pharmaceutical activation without requiring the user to manually operate the device or communicate with a healthcare provider. The system serves itself by making autonomous decisions about when activation is appropriate.
Solution Approach 2:
The wearable device continuously monitors contextual parameters and uses this feedback to determine when to activate the pharmaceutical. The system adjusts activation decisions based on real-time sensor data, creating a closed-loop control system that responds to changing conditions without human intervention.
3Manufacturing precision
If RF-activated nanoparticles are used, then targeted delivery is achieved, but healthcare provider intervention is needed for operation
Solution Approach 1:
The wearable device autonomously detects contextual conditions and triggers the pharmaceutical activation without requiring healthcare provider operation. The system independently monitors sensor data, processes contextual information, and activates the drug when predetermined conditions are met, fully automating the targeted delivery process.
Solution Approach 2:
The system replaces manual or provider-operated activation mechanisms with automated sensor-based detection and electronic triggering. Instead of a provider manually operating RF equipment, the wearable device uses integrated sensors and control circuitry to automatically initiate the activation sequence based on detected contextual conditions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The wearable device enables automatic and timely activation of pharmaceuticals, reducing side effects and discomfort by anticipating and responding to specific user contexts, ensuring pharmaceuticals are activated when needed to alleviate stress or pain effectively.
Implementation Method 1
radio frequency (RF) fields have been used to activate anti-cancer drugs only in the area of the body that the drug is needed. The drug is contained in lipid-polymer hybrid nanoparticles that react to the magnetic field generated by the radio frequency signals.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Disclosed in some examples are methods, machine readable mediums, and systems for automatic activation of pharmaceutical agents using wearable devices in response to detecting one or more contexts of the user which indicate the need for pharmaceuticals. In some examples, a wearable device may emit signals to automatically release or activate drugs that are already in a user in response to a particular context of the user. For example, if the user begins vigorous exercise, the system may activate a pain medication that was already previously ingested by the user to alleviate anticipated joint pain.